Application and Effectiveness Analysis of Internet-based Diabetes Prevention Program
1 other identifier
interventional
59
1 country
1
Brief Summary
This study was conducted to test the possibility of preventing or delaying the development of type 2 diabetes in individuals with impaired glucose tolerance and elevated fasting plasma glucose concentrations by internet-based diabetes prevention program.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_4 type-2-diabetes
Started Jan 2008
Longer than P75 for phase_4 type-2-diabetes
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2008
CompletedFirst Submitted
Initial submission to the registry
February 19, 2010
CompletedFirst Posted
Study publicly available on registry
March 12, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2013
CompletedResults Posted
Study results publicly available
September 12, 2014
CompletedSeptember 12, 2014
September 1, 2014
5.8 years
February 19, 2010
September 8, 2014
September 8, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Incidence of Type 2 Diabetes Mellitus
Incidence of type 2 diabetes mellitus
one year follow up
Study Arms (2)
Lifestyle counseling
ACTIVE COMPARATORStandard care
ACTIVE COMPARATORInterventions
In intervention group, counseling sessions are conducted weekly for 3 months, once per two weeks for 3 months, monthly for 18 months, and then once every two months for the remainder of the study.
In standard care group, counseling sessions are conducted only 6 times for 4 years
Eligibility Criteria
You may qualify if:
- Age of 30-69 years
- BMI ≥ 20 kg/m2
- Impaired glucose tolerance :
- h postprandial glucose (75 g OGTT) 140-199 mg/dl or Impaired fasting glucose : Fasting plasma glucose 110-125 mg/dl
You may not qualify if:
- Diabetes at baseline
- Cardiovascular disease, cancer requiring treatment in the past 5 years, renal disease
- Unable to communicate with clinic staff, Pregnancy and childbearing
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Chung-ju health care center
Chungju, Chungchungbook-do, South Korea
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Results Point of Contact
- Title
- Kun-Ho Yoon, professor
- Organization
- The Catholic University of Korea
Study Officials
- STUDY DIRECTOR
Kun-Ho Yoon, M.D., Ph.D.
Kangnam St.Mary's hospital
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor, Medical doctor
Study Record Dates
First Submitted
February 19, 2010
First Posted
March 12, 2010
Study Start
January 1, 2008
Primary Completion
November 1, 2013
Study Completion
November 1, 2013
Last Updated
September 12, 2014
Results First Posted
September 12, 2014
Record last verified: 2014-09